Author:
Bhat Laxminarayan,Hawkinson Jon,Cantillon Marc,Reddy Dasharatha G.,Bhat Seema R.,Laurent Charles-E.,Bouchard Annie,Biernat Marzena,Salvail Dany
Funder
Reviva Pharmaceuticals, Inc
Pharmaceuticals
Reference41 articles.
1. Formation of plexiform lesions in experimental severe pulmonary arterial hypertension;Abe;Circulation,2010
2. Sildenafil in the treatment of pulmonary hypertension;Barnett;Vasc. Health Risk Manag.,2006
3. An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL registry;Benza;Chest,2012
4. RP5063, a novel, multimodal, serotonin receptor modulator, prevents monocrotaline-induced pulmonary arterial hypertension in rats;Bhat;Eur. J. Pharmacol.,2017
5. RP5063, a novel, multimodal, serotonin receptor modulator, prevents Sugen 5416-hypoxia– induced pulmonary arterial hypertension in rats;Bhat;Eur. J. Pharmacol.,2017
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献